Literature DB >> 31240808

Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis.

Jennifer R Wang1, Zhannat Nurgalieva1, Shuangshuang Fu2, Samantha Tam1, Hui Zhao2, Sharon H Giordano2, Katherine A Hutcheson1, Carol M Lewis1.   

Abstract

BACKGROUND: Head and neck cancer (HNC) and its treatment lead to functional impairments. Rehabilitation by speech-language pathology (SLP) and occupational/physical therapy (OT/PT) can decrease morbidity.
METHODS: The Surveillance, Epidemiology and End Results-Medicare data for patients with HNC diagnosed between 2002 and 2011 was utilized to evaluate posttreatment rehabilitation.
RESULTS: In 16 194 patients, the overall utilization rate was 20.7% for SLP and 26.2% for OT/PT services. Treatment modality was significantly associated rehabilitation utilization. Compared to patients treated with primary surgery, those treated with primary radiotherapy had significantly lower odds of OT/PT utilization. Patients treated with surgery plus adjuvant treatment and primary concurrent chemoradiation had higher odds of SLP utilization compared to patients treated with surgery alone.
CONCLUSIONS: Rehabilitation services appeared to be underutilized by patients with HNC in the United States and vary with treatment modality. There is a need to improve integration of rehabilitation services into the HNC care continuum.
SUMMARY: Rehabilitation services are underutilized by patients with HNC during posttreatment surveillance in the United States. Treatment modality significantly impacts rehabilitation utilization patterns.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  head and neck cancer; occupational therapy; physical and rehabilitation medicine; rehabilitation research; speech-language pathology; survivorship

Mesh:

Year:  2019        PMID: 31240808     DOI: 10.1002/hed.25844

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Data mining of an acoustic biomarker in tongue cancers and its clinical validation.

Authors:  Yudong Xiao; Tao Wang; Wei Deng; Le Yang; Bin Zeng; Xiaomei Lao; Sien Zhang; Xiangqi Liu; Daiqiao Ouyang; Guiqing Liao; Yujie Liang
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.